Intchains Group
ICG
Mawson Infrastructure
MIGI
Ebang International
EBON
Argo Blockchain
ARBK
Hive Blockchain
HIVE
Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease.